Research on the Blood- Cooling - Toxin - Removing - Stasis - Dispersing Protocol Evaluation of Hench-schonlein Purpura

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Due to high incidence of renal damage by Hench-schonlein Purpura(HSP) is the key to affect prognosis, this project moves the research emphasis forward in line with the idea of "prevention of progress of disease", Which concerns on Traditional Chinese Medicine(TCM) clinical research scheme evaluation of HSP, evaluates the renal damage and disease recurrence as the end event, and comes to the evaluation through the comparative study that the vantage point of the scheme of syndrome differentiation and treatment in detoxification, cooling blood and removing blood stasis to the conventional treatments can reduce kidney damage and recurrence rate.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Liaoning University of Traditional Chinese Medicine
• Collaborators: Dalian Children's Hospital; Dongzhimen Hospital, Beijing; Shenyang Hospital of Integrated Traditional and westen Medicine

Criteria

Inclusion Criteria:

• To comply with the diagnostic standard of purpura in TCM and Hench-schonlein purpura in western medicine;

• To comply with the diagnostic standard of TCM syndrome differentiation;

• Age between 5 and 18;

• without similar herbal treatment a week before being included;

• Informed Consent Form is required to be singed.

Exclusion Criteria:

• Fall short of the diagnostic standard of purpura in TCM and Hench-schonlein purpura in western medicine;

• Fall short of the diagnostic standard of TCM syndrome differentiation;

• Older then 18 years or younger then 5years;

• Take similar herbal treatment within a week before being included;

• Can not take the drug according to the regulation or follow-up on time

• Patients combine serious primary disease in respiratory、gastrointestinal、hemopoietic、renal，or psychosis,or pestilence;

• Allergic to drugs of this research or others;

• human subject of other clinical research in the nearly tow weeks.